
Targeted Antibiotics for Trachoma: A Cluster-Randomized Trial
Author(s) -
Jason S Melo,
Solomon Aragie,
Ambahun Chernet,
Zerihun Tadesse,
Adane Dagnew,
Dagnachew Hailu,
Haile Mahteme,
Tàye Zeru,
Dionna M Wittberg,
Scott Nash,
E. Kelly Callahan,
Benjamin F. Arnold,
Travis C. Porco,
Thomas M. Lietman,
Jeremy D. Keenan
Publication year - 2021
Publication title -
clinical infectious diseases/clinical infectious diseases (online. university of chicago. press)
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.44
H-Index - 336
eISSN - 1537-6591
pISSN - 1058-4838
DOI - 10.1093/cid/ciab193
Subject(s) - trachoma , medicine , antibiotics , randomized controlled trial , cluster randomised controlled trial , intensive care medicine , microbiology and biotechnology , pathology , biology
Current guidelines recommend community-wide mass azithromycin for trachoma, but a targeted treatment strategy could reduce the volume of antibiotics required.